Regenxbio RGNX Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue (Gross) by Product | ||||||
| Nippon Shinyaku Services | $11.06M— | $11.82M— | —— | —— | —— | |
| Other Service Revenue | $2.46M+91.9% | $2.35M+71.9% | $985K— | $1M— | $1.28M— | |
| Total Service Revenue | $13.51M+343% | $14.17M+936% | $11.41M— | $5.5M— | $3.05M— | |
| Revenue by Product | ||||||
| License And Service | $74.31M-51.6% | $156.27M+90.7% | $149.91M+79.8% | $150.28M+70.2% | $153.67M+77.8% | |
| Service | $13.51M+343% | $14.17M+936% | $11.41M— | $5.5M— | $3.05M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Regenxbio break its business down?
- Regenxbio (RGNX) reports revenue (gross) by product across 4 parts — Nippon Shinyaku Services, Other Service Revenue, Total Service Revenue and Zolgensma And Itvisma Royalties. Each is extracted from the segment footnotes and tracked over time.
- Where does Regenxbio's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Regenxbio's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
